CRBNA Stock Overview
Provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Corbion N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €25.45 |
| 52 Week High | €25.46 |
| 52 Week Low | €18.02 |
| Beta | 0.98 |
| 11 Month Change | 4.35% |
| 3 Month Change | 20.27% |
| 1 Year Change | 44.03% |
| 33 Year Change | -39.89% |
| 5 Year Change | -10.76% |
| Change since IPO | 97.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| CRBNA | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.4% | -1.8% |
| 1Y | 44.0% | -19.1% | 5.8% |
Return vs Industry: CRBNA exceeded the UK Chemicals industry which returned -19.1% over the past year.
Return vs Market: CRBNA exceeded the UK Market which returned 5.8% over the past year.
Price Volatility
| CRBNA volatility | |
|---|---|
| CRBNA Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 6.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.0% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: CRBNA's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine CRBNA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 2,727 | Olivier Rigaud | www.corbion.com |
Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors.
Corbion N.V. Fundamentals Summary
| CRBNA fundamental statistics | |
|---|---|
| Market cap | €1.30b |
| Earnings (TTM) | €80.10m |
| Revenue (TTM) | €1.44b |
16.3x
P/E Ratio0.9x
P/S RatioIs CRBNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRBNA income statement (TTM) | |
|---|---|
| Revenue | €1.44b |
| Cost of Revenue | €1.10b |
| Gross Profit | €341.30m |
| Other Expenses | €261.20m |
| Earnings | €80.10m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 27, 2025
| Earnings per share (EPS) | 1.38 |
| Gross Margin | 23.71% |
| Net Profit Margin | 5.57% |
| Debt/Equity Ratio | 58.5% |
How did CRBNA perform over the long term?
See historical performance and comparison